School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, PR China.
Key Laboratory of Laboratory Medicine, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang, PR China.
Clin Chem Lab Med. 2020 Jul 16;59(1):91-99. doi: 10.1515/cclm-2020-0300.
Colorectal cancer (CRC) screening using stool samples is now in routine use where tumor DNA methylation analysis for leading markers such as NDRG4 and SDC2 is an integral part of the test. However, processing stool samples for reproducible and efficient extraction of human genomic DNA remains a bottleneck for further research into better biomarkers and assays.
We systematically evaluated several factors involved in the processing of stool samples and extraction of DNA. These factors include: stool processing (solid and homogenized samples), preparation of DNA from supernatant and pellets, and DNA extraction with column and magnetic beads-based methods. Furthermore, SDC2 and NDRG4 methylation levels were used to evaluate the clinical performance of the optimal protocol.
The yield of total and human genomic DNA (hgDNA) was not reproducible when solid stool scraping is used, possibly due to sampling variations. More reproducible results were obtained from homogenized stool samples. Magnetic beads-based DNA extraction using the supernatant from the homogenized stool was chosen for further analysis due to better reproducibility, higher hgDNA yield, lower non-hgDNA background, and the potential for automation. With this protocol, a combination of SDC2 and NDRG4 methylation signals with a linear regression model achieved a sensitivity and specificity of 81.82 and 93.75%, respectively.
Through the systematic evaluation of different stool processing and DNA extraction methods, we established a reproducible protocol for analyzing tumor DNA methylation markers in stool samples for colorectal cancer screening.
目前,粪便样本的结直肠癌(CRC)筛查已常规应用,肿瘤 DNA 甲基化分析,如 NDRG4 和 SDC2 等主要标志物,是该检测的重要组成部分。然而,为了进一步研究更好的生物标志物和检测方法,仍需要解决粪便样本处理以实现人类基因组 DNA 重复性和高效提取的问题。
我们系统地评估了粪便样本处理和 DNA 提取过程中涉及的几个因素。这些因素包括:粪便处理(固体和匀浆样本)、上清液和沉淀中 DNA 的制备,以及柱法和基于磁珠的方法提取 DNA。此外,我们还使用 SDC2 和 NDRG4 甲基化水平来评估最佳方案的临床性能。
当使用固体粪便刮取时,总 DNA(tgDNA)和人类基因组 DNA(hgDNA)的产量不可重复,这可能是由于采样的差异。匀浆粪便样本可获得更可重复的结果。由于更好的重复性、更高的 hgDNA 产量、更低的非 hgDNA 背景,以及自动化的潜力,我们选择了基于磁珠的上清液中 DNA 提取方法用于进一步分析。使用该方案,SDC2 和 NDRG4 甲基化信号的线性回归模型的灵敏度和特异性分别为 81.82%和 93.75%。
通过对不同粪便处理和 DNA 提取方法的系统评估,我们建立了一种可重复性的方案,用于分析粪便样本中结直肠癌筛查的肿瘤 DNA 甲基化标志物。